Medication info

Bielastraset Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Sungyi Bio Pharmaceutical Co., Ltd.
Appearance
Pale yellow, rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202107098 · Approved 2021.10.25

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly Administer the usual adult dose. However, because the elimination half-life of tramadol increases by 17% when tramadol is administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, this medicine does not need to be readministered after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Sungyi Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly Administer the usual adult dose. However, because the elimination half-life of tramadol increases by 17% when tramadol is administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, this medicine does not need to be readministered after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may put strain on the liver, so those who drink several servings of alcohol daily should consult with a physician or pharmacist before use. If a rash or allergic reaction occurs while taking this medication, discontinue use immediately and inform healthcare personnel. The ingredients in this medication can cause seizures, so individuals with a history of seizures or a high risk of seizures should exercise caution. Patients with impaired respiratory function or asthma may experience serious breathing problems while using this medication and should only use it in a monitored healthcare environment. Taking this medication with other sedatives or alcohol may cause respiratory depression or severe drowsiness, so co-administration should be avoided or done with extreme caution. Patients with head injuries or brain diseases should avoid this medication as there is a risk of decreased consciousness. This medication may cause dependence, so dosages and duration should be adjusted according to a physician's instructions when used for extended periods. Patients with severe liver or kidney impairment should avoid this medication or use it cautiously after consulting a physician. This medication should not be administered to children, especially those under 12 years of age, or to adolescents under 18 years of age after tonsil or adenoid surgery. Women who are pregnant or breastfeeding should consult a physician before taking this medication, and breastfeeding mothers are advised to discontinue breastfeeding while using this medication. This medication may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. In case of overdose, serious respiratory depression, seizures, liver damage, and other complications may occur, so adhere to the prescribed dosage and immediately visit a medical facility if unusual symptoms arise. There may be potential interactions with other medications during use, so inform healthcare personnel about any other medications being taken.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, profound sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, reduced libido, sleep disorders, disorientation, spatial disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, paresthesia, attention deficit, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual impairment, visual disorders, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, respiratory distress, dry throat, elevated liver enzymes, generalized pruritus, sweating, urination disorders, erectile dysfunction, myasthenia, chest pain, abnormal emotions, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, elevated blood creatinine, anaphylactic reaction, impact on unstable emotions, delirium, suicidal ideation, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait impairment, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematological disorders, hyponatremia, fixed rash, fever, edema, rigidity, fainting, congestive heart failure, vertigo, stupor, exacerbation of migraine, involuntary muscle contractions, exercise-induced respiratory distress, cough, bronchitis, urinary retention, frequency, abnormal kidney function values, oliguria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, bleeding, elevated cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, constipation, vomiting, dyspepsia, abdominal pain, dry mouth, diarrhea, hiccups, paralytic ileus, cholecystitis, abnormal kidney function values, increased salivation, bleeding, stupor, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, disorientation, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory tract syndrome, mouth twitching, excitement, irritability, hyperactivity, panic attack, severe anxiety, perceptual disturbances, tinnitus, abnormal central nervous system response, urticaria, bronchospasm, toxic skin necrosis, allergic reactions, withdrawal symptoms, anxiety, sweating, insomnia, rigidity, pain, nausea, tremors, diarrhea, upper respiratory tract syndrome, mouth twitching, excitement, irritability, hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius. This will help keep the medication's effectiveness and safety for a longer period.

Appearance and packaging

Appearance

Pale yellow, rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.